Helen Torley sold $3.7M of Halozyme Therapeutics (HALO)

Executed Aug 11 2025, disclosed Aug 13 2025, 2 days later.

Value, as filed

$3.7M

58,717 sh across 5 lots

Executed

Aug 11 2025

the trade date, as filed

Disclosed

Aug 13 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Helen Torley PRESIDENT AND CEO profile →

Helen Torley (PRESIDENT AND CEO) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $6.6M of HALO (59,600 sh across 10 lots, as filed), executed Oct 6.

The name

HALO

Halozyme Therapeutics, Inc. HALO · Healthcare · 38 filings in 24 months ticker →

Healthcare · Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Helen Torley in HALO

HALOSALE Halozyme Therapeutics, Inc. $6.6M
59,600 sh across 10 lots
Exec Oct 6
Filed Oct 8 · 7:56 PM ET HALOSALE Halozyme Therapeutics, Inc. $6.4M
59,900 sh across 6 lots
Exec Sep 9
Filed Sep 11 · 8:35 PM ET HALOSALE Halozyme Therapeutics, Inc. $6.1M
58,600 sh across 9 lots
Exec Aug 17
Filed Aug 19 · 8:01 PM ET HALOSALE Halozyme Therapeutics, Inc. $3.3M
49,600 sh across 8 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. $3.3M
47,902 sh across 9 lots
Exec May 11
Filed May 13 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. $635K
10,000 sh across 2 lots
Exec Apr 6
Filed Apr 7 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. $2.5M
39,000 sh across 3 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. $3.4M
49,422 sh across 6 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET